Preservative, Buffer, Anticoagulant Or Diluent Patents (Class 436/18)
-
Patent number: 11579139Abstract: A method for measuring concentrations of blood cell components is provided. The method comprises: obtaining a blood sample from a subject, the blood sample comprising at least one of red blood cells (RBCs), white blood cells (WBCs), and platelets (PLTs); mixing the blood sample with a non-lysing aqueous solution to form a sample mixture comprising a predetermined tonicity; passing the sample mixture through a flow cell; emitting light towards the flow cell; measuring at least one of an amount of light absorbed by the RBCs to obtain an RBC absorption value, an amount of light scattered by WBCs to obtain a WBC scatter value, and an amount of light scattered by PLTs to obtain a PLT scatter value; and determining a concentration of at least one of the RBCs, WBCs, and PLTs present in the sample mixture.Type: GrantFiled: December 22, 2021Date of Patent: February 14, 2023Assignee: LabThroughput LLCInventors: David Zelmanovic, John Roche
-
Patent number: 11022585Abstract: A plurality of chromatograms is run using a salt gradient with a range of constant pH values or using a pH gradient with a range of constant salt concentrations. A chromatography optimization algorithm can be used to identify at least one salt gradient chromatogram or at least one pH gradient chromatogram to establish optimized buffer conditions. The chromatography optimization algorithm can include a total number of peaks algorithm, a peak-to-valley algorithm, and/or a peak capacity algorithm.Type: GrantFiled: June 9, 2019Date of Patent: June 1, 2021Assignee: Dionex CorporationInventors: Shanhua Lin Liehr, Jung Un Baek, Christopher A. Pohl, Mark Lee Tracy, Xiadong Liu
-
Patent number: 10321861Abstract: The present invention relates to a pH sensor adapted to be inserted into all soft tissues, such as muscle, fat or other organs e.g. heart, lung, kidney, liver, pancreas, renal gland etc., comprising one or more of: a) means to provide sensor calibration performance information; b) a sensor dislodgement alert, providing an indication to the user if the pH reading falls outside a predetermined range; c) an alert to indicate that the sensor has exceeded its usage period; and d) an alert to indicate that the sensor had exceeded its shelf life. There is also provided a method of assessing the efficacy of a treatment regime comprising the steps of determining any change in the pH of the soft tissue during treatment, where any change in the pH towards the preferred range for the tissue type is indicative of an effective treatment regime and any change in the pH away from the preferred range for the tissue type is indicative of a worsening in the condition of the tissue, and thus an ineffective treatment regime.Type: GrantFiled: June 11, 2013Date of Patent: June 18, 2019Assignee: SOFTCELL MEDICAL LIMITEDInventor: Kirsty McIntosh
-
Patent number: 9551022Abstract: Provided is a method for measuring a substance in a blood sample, which allows avoidance of the influences of both of bilirubin and hemoglobin by simple operations. Provided is a method for measuring a substance in a blood sample by an enzymatic method using an oxidizable color reagent, the method including (1) bringing the blood sample into contact with a non-ionic surfactant; and then (2) bringing the resultant sample into contact with a betaine-type amphoteric surfactant, to perform an enzyme reaction and a color reaction by an oxidizable color reagent at the same time as the contact or after the contact.Type: GrantFiled: April 1, 2013Date of Patent: January 24, 2017Assignee: SEKISUI MEDICAL CO., LTD.Inventor: Toyomi Yamaguchi
-
Patent number: 9128105Abstract: A synthetic urine solution and method of its manufacture are disclosed. The solution includes water having a pH between about 3 and about 10. The solution further includes creatinine, a means for removing bacteria from the solution so as to control or eliminate sepsis of the urine solution, preferably through the use of a biocide, and a urea-based compound. The solution exhibits a specific gravity of from 1.005 g/cm3 to 1.025 g/cm3. Additional compounds may also be included to further enhance the aesthetics or apparent authenticity of the synthetic urine.Type: GrantFiled: May 6, 2014Date of Patent: September 8, 2015Assignee: Spectrum Laboratories, LLCInventor: James Matthew Stephens
-
Patent number: 9029154Abstract: A biological reaction apparatus for receiving at least one substrate having a sample located in a sample region, and a separate cover, such that a reaction chamber is formed between the cover and substrate over the sample region. The apparatus includes a substrate locator for locating the substrate; a cover locator for locating and moving the cover with respect to the substrate; a fluid dispenser for dispensing fluid into the reaction chamber; and a draining mechanism which includes a wick.Type: GrantFiled: February 1, 2010Date of Patent: May 12, 2015Assignee: Leica Biosystems Melbourne Pty LtdInventors: Stuart Elliot, Andrew McLellan, Chester Henderson, Mark Dockrill, Simon Harris, Peter Riddell
-
Patent number: 9022865Abstract: In some embodiments, a player may influence the volatility of a bonus round of a game by placing elements collected during a primary game onto symbol positions of the bonus round. In some embodiments, if a symbol position onto which a player placed one or more bonus round symbols is selected as an active symbol position for an event instance of the bonus round, the player wins a prize. Additionally, a multiplier may be applied to the value of the prize or other benefit may be provided to the player if the player placed more than one bonus round symbol element on the position. Thus, a player having a plurality of bonus round symbols to place may choose to increase the frequency of prizes won (e.g., by distributing the bonus round symbols over more positions) or increase the value of prizes (e.g., by grouping more symbols on fewer positions).Type: GrantFiled: April 26, 2013Date of Patent: May 5, 2015Assignee: Gamesys, Ltd.Inventors: Hans Elias, Thomas David James Aicken, Marlon James Dublin
-
Patent number: 8945928Abstract: The invention provides a novel array method for nucleic acid sequence detection with improved specificity which allows for detection of genetic variation, from simple SNPs (where the variation occurs at a fixed position and is of limited allelic number) to more complex sequence variation patterns (such as with multigene families or multiple genetic strains of an organism where the sequence variation between the individual members is neither fixed nor consistent). The array is comprised of short, synthetic oligonucleotide probes attached to a solid surface which are hybridized to single-stranded targets. Single stranded targets can be produced using a method that employs primers modified on the 5? end to prohibit degradation by a 5?-exonuclease that is introduced to degrade the unprotected strand. The invention further provides for printing buffers/solutions for the immobilization of oligonucleotide probes to an array surface.Type: GrantFiled: June 6, 2013Date of Patent: February 3, 2015Inventors: Kerry B Gunning, Mark Aaron Behlke
-
Publication number: 20150024502Abstract: Methods for stabilizing reference standards used in total organic carbon (TOC) analysis of water and pharmaceutical samples are disclosed. The methods include adding a preservative to TOC reference standards. The preservative is selected from the group consisting of copper (II) sulfate and hydrogen sulfite. Compositions of the stabilized reference standards are also disclosed.Type: ApplicationFiled: January 9, 2012Publication date: January 22, 2015Inventor: Shouquan Deng
-
Patent number: 8921113Abstract: A buffer kit includes a first eluent and second eluent. The first eluent solution includes at least four buffer salts where at least three of the four buffer salts are a monovalent buffer salt, have a net negative charge or a net neutral zwitterionic charge, and include a sulfonate group and an amine. The second eluent solution includes at least four buffer salts where at least three of the four buffer salts are a monovalent buffer salt, have a net negative charge or a net neutral zwitterionic charge, and include a sulfonate group and an amine. The first eluent solution has a first pH and the second eluent solution has a second pH where the first pH and second pH are different values. The buffer kit provides a linear pH gradient that forms an approximately straight line from at least the first pH to the second pH.Type: GrantFiled: December 21, 2012Date of Patent: December 30, 2014Assignee: Dionex CorporationInventors: Shanhua Lin, Christopher A. Pohl
-
Patent number: 8877505Abstract: Embodiments of a composition for stabilizing fluorescent signal of nanoparticles and methods for its use are disclosed. In some embodiments, the composition has a pH from 7 to 10 and includes borate, protein and/or protein hydrolysate, an amine, a preservative, and a nonionic surfactant. In particular embodiments, the amine is an N-ethanol substituted amine, such as ethanolamine, diethanolamine, triethanolamine, N-methyldiethanolamine, N,N-dimethylethanolamine, or a combination thereof. In some embodiments, a fluorescent particle solution, such as a quantum dot solution or quantum dot conjugate solution, is diluted in the composition and stored at 4° C. In certain embodiments, the fluorescence intensity of the diluted fluorescent particle remains substantially the same when stored at 4° C. for at least one month or at least three months. In particular embodiments, a diluted quantum dot conjugate is used to detect a hybridized probe or a protein antigen.Type: GrantFiled: February 1, 2011Date of Patent: November 4, 2014Assignee: Ventana Medical Systems, Inc.Inventors: Eric May, Alexandra Nagy, Jerome Kosmeder
-
Patent number: 8865416Abstract: Analyte sensors, methods for producing and using analyte sensors, methods of detecting and/or measuring analyte activity, detecting pH change, and/or, controlling the concentration of an analyte in a system, are disclosed. Embodiments of the analyte sensors according to the disclosure can provide an accurate and convenient method for characterizing analyte activity, detecting pH change, controlling the concentration of an analyte in a system, and the like, in both in vivo and in vitro environments, in particular in living cell imaging.Type: GrantFiled: October 19, 2011Date of Patent: October 21, 2014Assignee: Georgia State University Research Foundation, Inc.Inventors: Jenny Jie Yang, Shen Tang
-
Patent number: 8845415Abstract: In various embodiments, players around the casino may predict cards to be dealt in a game of blackjack.Type: GrantFiled: July 6, 2012Date of Patent: September 30, 2014Assignee: CFPH, LLCInventors: Howard W. Lutnick, Dean P. Alderucci, Geoffrey M. Gelman, Kevin Burman
-
Patent number: 8802385Abstract: The present invention relates to a new suspension medium or diluent solution for red blood cells for use in haematological methods. The suspension medium or diluent solution for red blood cells may comprise a combination of two or more amino acids of any group, and preserves the red blood cells in the sample for at least 8 weeks.Type: GrantFiled: June 22, 2007Date of Patent: August 12, 2014Assignee: Grifols, S.A.Inventors: Daniel Martorell Pena, Ma del Carmen Traves Polo, Jordi Farre Leon, Josefina Castells Parera
-
Patent number: 8796028Abstract: The invention relates to a method for treating a biological sample, comprising the following method steps: i) preparation of a biological sample and ii) bringing the biological sample into contact with a composition, comprising: (1) 1 to 100 wt. % of at least one polyol and (2) 0 to 99 wt. % of at least one additive, wherein the total amount of components (1) and (2) is 100 wt. %. The invention further relates to biological samples obtained by said method, a method for analysis of a treated biological sample, devices for treating a biological sample, use of said devices, various kits and use of a composition.Type: GrantFiled: December 29, 2006Date of Patent: August 5, 2014Assignee: Qiagen GmbHInventor: Vera Holländer
-
Patent number: 8785201Abstract: The invention relates to improved electrochemiluminescence assay methods for phosphorylated peptides or proteins employing phospho-specific antibodies and buffer compositions that are substantially free of inorganic phosphate.Type: GrantFiled: February 10, 2009Date of Patent: July 22, 2014Assignee: Meso Scale Technologies, LLCInventors: Michael Tsionsky, Eli N. Glezer, Selen Altunata, George Sigal, Jonathan K. Leland, Mark A. Billadeau, Svetlana Leytner, Mark Martin, Larry Helms
-
Publication number: 20140179008Abstract: A buffer kit includes a first eluent and second eluent. The first eluent solution includes at least four buffer salts where at least three of the four buffer salts are a monovalent buffer salt, have a net negative charge or a net neutral zwitterionic charge, and include a sulfonate group and an amine. The second eluent solution includes at least four buffer salts where at least three of the four buffer salts are a monovalent buffer salt, have a net negative charge or a net neutral zwitterionic charge, and include a sulfonate group and an amine. The first eluent solution has a first pH and the second eluent solution has a second pH where the first pH and second pH are different values. The buffer kit provides a linear pH gradient that forms an approximately straight line from at least the first pH to the second pH.Type: ApplicationFiled: December 21, 2012Publication date: June 26, 2014Inventors: Shanhua LIN, Christopher A. POHL
-
Patent number: 8753888Abstract: The invention relates to methods of isolating white blood cells (WBCs) from a sample, e.g., whole blood, using magnetic particles that specifically bind to WBCs and a series of specific steps and conditions. The methods can include one or more of decreasing the viscosity of the sample prior to WBC isolation, agitating the sample at specified frequencies, and/or using a sample container arranged such that all of the sample is placed in close proximity (e.g., within 5, 2, 1, or 0.5 mm) to the source of the magnetic field. The new methods provide for isolation of WBC preparations with high yield, purity, and viability. The methods are designed for compatibility with automation protocols for rapid processing of multiple samples.Type: GrantFiled: May 25, 2012Date of Patent: June 17, 2014Assignee: The General Hospital CorporationInventors: Denise L. Faustman, Douglas E. Burger
-
Patent number: 8753836Abstract: Dewaxing buffers containing a water-soluble organic solvent, methods for use thereof, and kits incorporating dewaxing buffers. The dewaxing buffers contain a water soluble organic solvent that has a boiling point of at least 80° C. The dewaxing buffers described herein can be used to quickly and efficiently remove embedding paraffin from slide-mounted tissue sections in an aqueous buffer solution at elevated temperature without fear of paraffin redeposition of the slides. In addition, the dewaxing buffers described herein can be used to perform dewaxing and HIER in a single step, which can substantially reduce protocol time and lower the risk of sample loss or damage.Type: GrantFiled: January 23, 2012Date of Patent: June 17, 2014Assignee: Richard-Allan Scientific CompanyInventors: Jennifer H. Freeland, Marsha A. Harvey
-
Patent number: 8703490Abstract: Histochemical process compositions comprising at least one nanoparticle in an amount effective to reduce or substantially eliminate the average number of spots per slide that result from a sample staining protocol are disclosed. Various nanoparticles, or combinations thereof, including metals, metal alloys, metal oxides, ceramics, functionalized metals or metalloids, and other miscellaneous nanoparticles, such as carbon nanoparticles and diamond nanoparticles, can be used. The nanoparticle concentration typically is from about 2 parts per million to about 20 parts per million. One embodiment of a disclosed method concerns applying a histochemical process composition to a sample, followed by performing a staining protocol on the sample. Particular embodiments concern dispensing a nanosolution onto a sample using an automated system, heating the sample, and performing a sample staining process.Type: GrantFiled: June 1, 2009Date of Patent: April 22, 2014Assignee: Ventana Medical Systems, Inc.Inventors: Merrill Jackson, Michael Herman, Grace Hoben, Noemi Sebastiao, Scott Cockayne, Heather Ferrea
-
Patent number: 8669111Abstract: The present invention provides reagents and methods for limiting adsorptive and/or oxidative protein losses in a sample.Type: GrantFiled: January 24, 2013Date of Patent: March 11, 2014Assignee: Arizona Board of Regents, A Body Corporate of the State of Arizona Acting for and on Behalf of Arizona State UniversityInventors: Douglas Rehder, Matthew Schaab, Chad Borges
-
Patent number: 8647878Abstract: The invention relates to an immersion liquid including at least one compound of the general formula I in which R1 and R2 each include at least one ring structure and X denotes: O, S, NR3 with R3 selected from hydrogen or hydrocarbon, wherein Y denotes independently of each other O, S or NR4 with R4 selected from hydrogen or hydrocarbon. In addition, the invention relates to a further immersion liquid, a compound for an immersion liquid and a use of the immersion liquids or of the compound as an immersion oil for a microscope, in particular for a near-field microscope.Type: GrantFiled: February 24, 2010Date of Patent: February 11, 2014Assignee: Carl Zeiss AGInventor: Hans-Joachim Weippert
-
Patent number: 8617895Abstract: The present invention is directed to a pre-coated substrate, such as a slide, that is useful for immobilizing a sample. The invention is further provides methods of preparing such pre-coated substrates and methods of analyzing biological samples immobilized on such pre-coated substrate. The substrate is coated with a polycationic polymeric coating material specifically selected such that that coated substrate exhibits increased stability and prolonged shelf-life. Preferred polymeric coating materials include allylic or vinylic polymers having cationic groups thereon and having no more than a small percentage of peptidic monomeric linkages, particularly polydiallyldimethylammonium (PDDA).Type: GrantFiled: September 22, 2005Date of Patent: December 31, 2013Assignee: Tripath Imaging, Inc.Inventors: William Alan Fox, William Carl Ray, III
-
Patent number: 8597954Abstract: The present invention relates to a stool sample processing method and stool sample processing container the a stool sample processing container provided with a stool collection tool, a suspending solution holding portion and a processing solution holding portion, wherein stool sample preparation solutions consisting of a suspending solution and a stool sample processing solution are respectively housed in a suspending solution holding container and a processing solution holding container, after first mixing a stool sample with the suspending solution and suspending therein, a sealant is released into the suspending solution holding container by pressing on the lower portion of the processing solution holding container, and the resulting stool suspension mixes with the stool sample processing solution that stabilizes the nuclide acid.Type: GrantFiled: November 11, 2010Date of Patent: December 3, 2013Assignee: Olympus CorporationInventors: Yasuo Tanigami, Kazue Nakajima, Takami Shibazaki
-
Patent number: 8546075Abstract: A method of treating samples containing hepatitis C virus (HCV) which method comprises treating HCV-containing samples with a treating agent containing (1) an acidifying agent, and (2) a protein-denaturing agent, or an amphoteric surfactant or a cationic surfactant having both a straight chain alkyl group of 10 or more carbon atoms and a tertiary amine or a quaternary ammonium salt in the same molecule, to effect the release of the HCV antigen and the inactivation of antibodies that bind to the HCV antigen, and the like.Type: GrantFiled: October 28, 2004Date of Patent: October 1, 2013Assignee: Advanced Life Science Institute, Inc.Inventors: Katsumi Aoyagi, Kumiko Iida, Naoko Matsubara
-
Patent number: 8517967Abstract: The present invention provides modified platelets having a reduced platelet clearance and methods for reducing platelet clearance. Also provided are compositions for the preservation of platelets. The invention also provides methods for making a pharmaceutical composition containing the modified platelets and for administering the pharmaceutical composition to a mammal to mediate hemostasis.Type: GrantFiled: November 8, 2011Date of Patent: August 27, 2013Assignee: Velico Medical, Inc.Inventors: Keith Rosiello, Henrik Clausen
-
Patent number: 8506898Abstract: A kit is provided for gathering biological specimens. The kit generally comprises a self-contained specimen gathering device including a protective housing and a preservation solution. Also provided is a method of gathering specimens and a holistic method of deterring crime using the kit.Type: GrantFiled: July 16, 2008Date of Patent: August 13, 2013Assignee: Perez Forensic Strategies, LLCInventor: Vincent I. Perez
-
Publication number: 20130189169Abstract: The present invention provides reagents and methods for limiting adsorptive and/or oxidative protein losses in a sample.Type: ApplicationFiled: January 24, 2013Publication date: July 25, 2013Applicant: Arizona Board of Regents, a body corporate acting for and on behalf of Arizona State UniversityInventor: Arizona Board of Regents, a body corporate acting for and on behalf of Arizona State University
-
Patent number: 8445284Abstract: The formulations, systems, and methods disclosed herein permit automated preparation of specimens (e.g., biological specimens) for examination. The formulations can include a cytological fixative solution including Azure B, a surfactant, methanol, and ethylene glycol. The disclosed formulations, systems, and methods provide fast, efficient, and highly uniform specimen processing using minimal quantities of fluids. The methods include at least a fixing phase for fixing a specimen to a substrate such as a microscope slide, a staining phase for staining the specimen, and a rinsing phase for rinsing the specimen. One or more of the fixing, staining, and rinsing phases include one or more agitation phases for distributing reagents evenly and uniformly across the specimen. The systems can be implemented as a standalone device or as a component in a larger system for preparing and examining specimens.Type: GrantFiled: June 18, 2012Date of Patent: May 21, 2013Assignee: Constitution Medical, Inc.Inventors: Daniel Lapen, Kerri Licari
-
Patent number: 8438898Abstract: Methods and systems for preparation of calibrant infusion fluid sources are disclosed. In one embodiment, a precise volume of glucose is injected into a saline-solution filled calibrant infusion fluid source proximate in time to conducting a calibration procedure. The glucose concentration in the calibrant infusion fluid source is subsequently calculated based on the measured weight of the saline-solution, as determined prior to glucose injection, and the volume of glucose injected. This method provides a highly accurate and convenient manner for use in a hospital environment, for example, with an intravenous blood glucose sensor system. In another embodiment, a premixed calibrant infusion fluid source is provided that includes saline solution and a predetermined concentration of glucose. In such embodiments, shelf life problems related to water evaporation are mitigated by hermetically covering or otherwise hermetically containing the calibrant infusion fluid source up until the point of use.Type: GrantFiled: June 30, 2010Date of Patent: May 14, 2013Assignee: Edwards Lifesciences CorporationInventors: James R. Petisce, Michael J. Higgins, Kristie Trinh, Todd Abraham
-
Patent number: 8430747Abstract: A gaming system including a central server linked to a plurality of gaming machines and a plurality of bonus awards. The central server monitors wagers on the gaming machines. Based at least in part on the wagers the central server determines when bonus events will occur and which gaming machine(s) will provide the bonus awards. In one embodiment, the central server determines which gaming machine will provide a primary bonus award and any secondary bonus awards, wherein at least one gaming machine may be provided a plurality of bonus awards.Type: GrantFiled: July 30, 2007Date of Patent: April 30, 2013Assignee: IGTInventors: Carl V. Kniesteadt, Anthony J. Baerlocher, James A. Vasquez, Tonja M. Ferry, Erick T. Ching
-
Patent number: 8377695Abstract: A synthetic urine solution is described. The synthetic urine solution is a shelf stable, food grade composition formed of water having a pH between 3 and 10. A thickening agent is dissolved within the water to form a solution having a specific gravity between 1.025 g/cm3 and 1.225 g/cm3. To provide a realistic appearance and odor, a coloring agent and urea are dissolved within the solution. Finally, to provide a shelf stable product, a preservative is also dissolved within the solution.Type: GrantFiled: April 2, 2012Date of Patent: February 19, 2013Inventor: Brady Alfred Daniel
-
Patent number: 8357539Abstract: An activated partial thromboplastin time measuring reagent, including a first reagent containing a phospholipid and an activator and a second reagent containing a herparin neutralizer and a calcium salt is disclosed. An activated partial thromboplastin time measuring method, and a determination method for determining a presence or absence of a blood coagulation inhibitor are also disclosed.Type: GrantFiled: December 22, 2010Date of Patent: January 22, 2013Assignee: Sysmex CorporationInventors: Kazuyo Yoshida, Masahiro Okuda
-
Patent number: 8343769Abstract: An immersion solution for a microscope, the immersion solution including a metal-halogeno complex anion containing bromine or iodine and one or more types of metal elements M selected from Sn, In, Bi, Sb, Zn and Al, and an imidazolium cation, a pyridinium cation, a pyrrolidinium cation or an ammonium cation. The immersion solution includes an ionic liquid that transmits light having a predetermined wavelength, has a refractive index of no less than 1.60 and is used for a fluorescence microscope.Type: GrantFiled: December 8, 2011Date of Patent: January 1, 2013Assignee: Olympus Medical Systems Corp.Inventors: Hiroaki Kinoshita, Atsushi Niwa, Masahiro Sato
-
Patent number: 8329943Abstract: A method of stabilizing a hem protein which is effective against the denaturation and degradation of a hem protein typified by hemoglobin and a storage solution therefor. A method of stabilizing a hem protein and a storage solution therefor characterized in that an iminocarboxylic acid or its salt is made to coexist in a sample containing the hem protein, wherein the above-described iminocarboxylic acid is a compound represented by the following general formula (1) wherein R represents a hydrogen atom or a hydroxyl group; and X's represent each a hydrogen atom, an alkali metal or an ammonium group.Type: GrantFiled: October 6, 2008Date of Patent: December 11, 2012Assignee: Eiken Chemical Co., Ltd.Inventor: Shin Sugo
-
Patent number: 8318418Abstract: Provided are methods for determining the presence or amount of testosterone in a test sample, comprising ionizing all or a portion of the testosterone present in the sample to produce one or more testosterone ions that are detectable in a mass spectrometer. All or a portion of the testosterone present in the sample is ionized to produce one or more testosterone ions, which may be isolated and fragmented to produce precursor ions. A separately detectable internal testosterone standard can be provided in the sample. In a preferred embodiment, the reference is 2,2,4,6,6-d5 testosterone.Type: GrantFiled: October 28, 2009Date of Patent: November 27, 2012Assignee: Quest Diagnostics Investments IncorporatedInventors: Michael P. Caulfield, Darren A Carns, Richard E Reitz
-
Patent number: 8304243Abstract: A reagent for classification of leukocytes includes (a) at least two cationic surfactants; (b) at least one organic compound bearing a hydrophobic group and an anionic group; (c) a buffer for adjusting pH into a range of approximately 2-8. Also disclosed is a method for classifying leukocytes with the reagent. With the reagent and method, erythrocytes are lysed rapidly and classification of leukocytes into five groups is achieved in the same channel. The reaction may be carried out at approximately between 10-40° C. and scattered light signals may be detected at two angles for measuring the classification of leukocytes into five groups.Type: GrantFiled: March 23, 2012Date of Patent: November 6, 2012Assignee: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.Inventors: Bing Liu, Wenjuan Xu, Xiangping Meng, Yanmei Qiao, Mulong Liu
-
Patent number: 8273580Abstract: The invention provides an accurate, economical, automatable, high throughput method for the determination of the concentration of glycosaminoglycan anticoagulants, including low molecular weight heparin (LMWH) anticoagulants, in aqueous solutions. A method for cleaning a unit of manufacturing equipment used in the preparation of a LMWH to obtain an acceptable residual concentration of LMWH is further provided.Type: GrantFiled: July 5, 2011Date of Patent: September 25, 2012Assignee: Active BioMaterials, LLCInventors: Ralph Yamamoto, Yumi Kim
-
Patent number: 8232105Abstract: Certain embodiments described herein are directed to a reagent that includes an effective amount of an adsorber to remove interfering species present during heavy metal level measurement in a fluid sample. In some examples, the reagent can include an effective amount of an adsorber to remove a suitable amount of glutathione from the fluid sample such that the glutathione does not interfere with measurements of lead levels in the fluid sample.Type: GrantFiled: September 30, 2010Date of Patent: July 31, 2012Assignee: Magellan Biosciences Point-of-Care, Inc.Inventor: W James Scott
-
Patent number: 8187886Abstract: The invention relates to methods of isolating white blood cells (WBCs) from a sample, e.g., whole blood, using magnetic particles that specifically bind to WBCs and a series of specific steps and conditions. The methods can include one or more of decreasing the viscosity of the sample prior to WBC isolation, agitating the sample at specified frequencies, and/or using a sample container arranged such that all of the sample is placed in close proximity (e.g., within 5, 2, 1, or 0.5 mm) to the source of the magnetic field. The new methods provide for isolation of WBC preparations with high yield, purity, and viability. The methods are designed for compatibility with automation protocols for rapid processing of multiple samples.Type: GrantFiled: January 10, 2011Date of Patent: May 29, 2012Assignee: The General Hospital CorporationInventors: Denise L. Faustman, Douglas E. Burger
-
Patent number: 8183046Abstract: A method for preparing a composition that includes selecting a pH of the composition; selecting a first buffer with a negative temperature coefficient; selecting a second buffer with a positive temperature coefficient; and forming the composition comprising the first buffer and the second buffer. The composition has an average temperature coefficient, ?pH/?T(Ta,Tb)?1×10?3 pH-unit/K and a ?pH(Ta,Tb)?0.31 pH-unit for Ta=4 K and Tb=313 K.Type: GrantFiled: January 11, 2007Date of Patent: May 22, 2012Assignee: The Board of Trustees of the University of IllinoisInventors: Yi Lu, Hee-Jung Hwang, Nathan Sieracki, Dewain Garner
-
Patent number: 8163559Abstract: A reagent for four-part differentiation of white blood cells is provided. In one embodiment the reagent has an osmolality below 50 mOsm/kg H2O. A method for differentiating white blood cells using the reagent is also provided. The disclosure provides for a rapid lysis of red blood cells and four-part differentiation of white blood cells. The reagent may be simple in components and a surfactant is not necessary, but optional. A wide range of pH values may be suitable for the reagent.Type: GrantFiled: January 28, 2011Date of Patent: April 24, 2012Assignee: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.Inventors: Yanmei Qiao, Bing Liu, Xiangping Meng, Wenjuan Xu, Mulong Liu
-
Patent number: 8148156Abstract: A synthetic urine solution is described. The synthetic urine solution is a shelf stable, food grade composition formed of water having a pH between 3 and 10. A thickening agent is dissolved within the water to form a solution having a specific gravity between 1.025 g/cm3 and 1.225 g/cm3. To provide a realistic appearance and odor, a coloring agent and urea are dissolved within the solution. Finally, to provide a shelf stable product, a preservative is also dissolved within the solution.Type: GrantFiled: November 12, 2009Date of Patent: April 3, 2012Inventor: Brady Alfred Daniel
-
Patent number: 8143064Abstract: A reagent for classification of leukocytes includes (a) at least two cationic surfactants; (b) at least one organic compound bearing a hydrophobic group and an anionic group; (c) a buffer for adjusting pH into a range of approximately 2-8. Also disclosed is a method for classifying leukocytes with the reagent. With the reagent and method, erythrocytes are lysed rapidly and classification of leukocytes into five groups is achieved in the same channel. The reaction may be carried out at approximately between 10-40° C. and scattered light signals may be detected at two angles for measuring the classification of leukocytes into five groups.Type: GrantFiled: November 5, 2008Date of Patent: March 27, 2012Assignee: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.Inventors: Bing Liu, Wenjuan Xu, Xiangping Meng, Yanmei Qiao, Mulong Liu
-
Patent number: 8137987Abstract: Bodily fluid is analyzed for the presence of drugs of a selected panel of drugs in a simultaneous assay in which sample of the fluid is incubated with additional amounts of all drugs of the panel, antibodies specific to each of the drugs of the panel, and microparticles, the microparticles being divided into subsets, one subset for each drug in the panel and each subset distinguishable from the others. The incubation is performed in a liquid medium in which competitive binding occurs, the drugs in the sample competing with those added to the assay medium for binding to the antibodies. In one procedure, the added drugs are pre-coupled to the microparticles while the antibodies are not, and the incubation is followed by further incubating the microparticles with labeled ligands that have affinity for the antibodies.Type: GrantFiled: April 13, 2011Date of Patent: March 20, 2012Assignee: Bio-Rad Laboratories, Inc.Inventors: William F. Link, Renato B. del Rosario, Randy V. Sweet, David L. King
-
Patent number: 8105840Abstract: Described are a urine pretreatment agent, a urine pretreatment method, and a urinary protein quantitation method which reduce or cancel the influences of urine pH variations, cancel the influences of precipitates of urinary inorganic salts, and solubilize membrane proteins. The urine pretreatment agent for urinary protein quantitation, includes a buffer, a chelating agent, and a surfactant; the urine pretreatment method includes a step of mixing 10 to 1000 parts by mass of the urine pretreatment agent of the present invention with 100 parts by mass of urine; and the urinary protein quantitation method includes steps of: mixing 10 to 1000 parts by mass of the urine pretreatment agent with 100 parts by mass of urine; and then measuring the protein concentration.Type: GrantFiled: September 26, 2008Date of Patent: January 31, 2012Assignees: Niigata University, Denka Seiken Co., Ltd.Inventors: Masanori Hara, Akihiko Saito, Shinya Ogasawara, Yoshiaki Hirayama, Hiroyuki Kurosawa
-
Publication number: 20120003743Abstract: An object of the present invention is to provide a control material which can be preferably employed in detection of 1,5-anhydro-D-glucitol and glycoalbumin, which are employed as excellent indices for diabetes. The present inventor has found that mannitol which is added to serum or plasma used as control material stabilizes 1,5-anhydro-D-glucitol and glycoalbumin present in the serum or plasma for a long period of time, and that the object can be attained through provision of (1) an agent for stabilizing control material, the agent being composed of mannitol and (2) control material containing mannitol and 1,5-anhydro-D-glucitol.Type: ApplicationFiled: March 4, 2010Publication date: January 5, 2012Applicant: BML, INC.Inventor: Isami Tsuboi
-
Patent number: 8080423Abstract: Stabilizers for colorants used for detection of enzymatic reactions, having a cyclodextrin and a catalase; reagents including stabilizers; and methods of use of such stabilizers and reagents.Type: GrantFiled: August 4, 2005Date of Patent: December 20, 2011Assignee: Asahi Kasei Pharma CorporationInventors: Takuji Kouzuma, Yoko Nagai, Shigeyuki Imamura
-
Patent number: 8071317Abstract: Methods and reagents are disclosed for pretreating a sample suspected of containing a hydrophobic drug for conducting an assay method for detecting the hydrophobic drug. A combination is provided in a medium. The combination comprises (i) the sample, (ii) a releasing agent for releasing the hydrophobic drug and the metabolites from endogenous binding moieties, and (iii) a selective solubility agent that provides for substantially equal solubility of the hydrophobic drug and the metabolites in the medium. The selective solubility agent comprises a water miscible, non-volatile organic solvent and is present in the medium in a concentration sufficient to provide for substantially equal solubility of the hydrophobic drug and the metabolites in the medium. The medium, which may further comprise a hemolytic agent, is incubated under conditions for releasing the hydrophobic drug and the metabolites from endogenous binding moieties.Type: GrantFiled: February 14, 2011Date of Patent: December 6, 2011Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Tie Q. Wei, Alan Craig, Amy Posey
-
Patent number: 8012753Abstract: The present invention provides methods for regrowth of conifer embryogenic cells. The methods comprise the steps of (a) contacting cryopreserved conifer embryogenic cells with a liquid transition medium, and (b) culturing the contacted conifer embryogenic cells in a regrowth medium to generate regrowth of the conifer embryogenic cells. Generally, the cryopreserved conifer embryogenic cells are contacted with the liquid transition medium for less than about 24 hours, such as for about one hour.Type: GrantFiled: June 24, 2004Date of Patent: September 6, 2011Assignee: Weyerhaeuser NR CompanyInventors: Pramod K. Gupta, Bonnie Larson, Doris Budworth